The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older
Public ClinicalTrials.gov record NCT06015282. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Observer-Blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of a MF59-Adjuvanted Quadrivalent Subunit Cell-derived Influenza Vaccine (aQIVc) in Comparison With Quadrivalent Influenza Vaccines, in Adults Aged 50 Years and Older.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately 7700 male and female adults aged 50 years and older (approximately equally split between two age groups: 50-64 years; 65 years and older), who are healthy or have stable comorbidities that increase their risk of complications from influenza infection. Three lots of aQIVc will be evaluated for consistency and pooled for the comparison with the 2 control vaccines. Subjects will be randomly assigned to receive 1 of 3 lots of aQIVc, QIVr, or aQIV in a 1:1:1:2:2 ratio (for a 3:2:2 ratio for aQIVc, QIVr, and aQIV). The study will have a treatment period (Day 1 to Day 29) and a follow-up period (Day 30 up to Day 181); a subset of 770 subjects will be followed up up to Day 365.
Study identification
- NCT ID
- NCT06015282
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 7,741 participants
Conditions and interventions
Conditions
Interventions
- Investigational aQIVc Biological
- licensed QIVr Biological
- licensed aQIV Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2023 (Actual)
- Primary completion
- Mar 5, 2024 (Actual)
- Completion
- Jan 30, 2025 (Actual)
- Last update posted
- Apr 27, 2025
2023 – 2025
United States locations
- U.S. sites
- 51
- U.S. states
- 25
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance for Multispecialty Research (AMR) Phoenix | Tempe | Arizona | 85281 | — |
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Marvel Clinical Research | Huntington Beach | California | 92647 | — |
| Paradigm Clinical Research Center, LLC | Redding | California | 96001 | — |
| Clinical Research Consulting, Inc. | Milford | Connecticut | 06460 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Innovative Research of West Florida, Inc. | Clearwater | Florida | 33756 | — |
| USA and International Research Inc. | Doral | Florida | 33126 | — |
| Velocity Clinical Research, New Smyrna Beach | Edgewater | Florida | 32132 | — |
| Health Awareness, Inc. | Jupiter | Florida | 33458 | — |
| ARS - Lake Oconee | Largo | Florida | 33777 | — |
| Global Health Research Center | Miami Lakes | Florida | 33016 | — |
| Precision Clinical Research | Sunrise | Florida | 33351 | — |
| Global Health Research center | Tampa | Florida | 33615 | — |
| Velocity Clinical Research- Boise | Meridian | Idaho | 83642 | — |
| Great Lakes Clinical Trials, LLC Ravenswood dba Flourish Research | Chicago | Illinois | 60640 | — |
| Great Lakes Clinical Trials, LLC. Ravenswood dba Flourish Research | Gurnee | Illinois | 60031 | — |
| Velocity Clinical Research Valparaoso | Valparaiso | Indiana | 46383 | — |
| Velocity Clinical Research, Sioux City | Sioux City | Iowa | 51106 | — |
| Velocity Clinical Research, Baton Rough | Baton Rouge | Louisiana | 70809 | — |
| Benchmark Research | Metairie | Louisiana | 70006 | — |
| IMA Evaluations LLC | Monroe | Louisiana | 71201 | — |
| Centennial Medical Group, PC | Columbia | Maryland | 21075 | — |
| Velocity Clinical Research Rockville | Rockville | Maryland | 20854 | — |
| Velocity Clinical Research Gulfport | Gulfport | Mississippi | 39503 | — |
| Alliance for Multispecialty Research, LLC | Kansas City | Missouri | 64114 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Velocity Clinical Research, Norfolk | Norfolk | Nebraska | 68701 | — |
| Velocity Clinical Research, Omaha | Omaha | Nebraska | 68134 | — |
| Alliance for Multispecialty Research (AMR) LLC, Las Vegas | Las Vegas | Nevada | 89119 | — |
| Velocity Clinical Research, Binghamton | Binghamton | New York | 13905 | — |
| Velocity Clinical Research, Syracuse | East Syracuse | New York | 13057 | — |
| Velocity Clinical Research, Vestal | New York | New York | 13850 | — |
| M3 Wake Research, Inc | Raleigh | North Carolina | 27612 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| Velocity Clinical Research Cincinnati | Cincinnati | Ohio | 45242 | — |
| Velocity Clinical Research, Cleveland | Cleveland | Ohio | 44122 | — |
| Velocity Clinical Research - Medford | Medford | Oregon | 97504 | — |
| Velocity Clinical Research-Providence | East Greenwich | Rhode Island | 02818 | — |
| Velocity Clinical Research, Gaffney | Gaffney | South Carolina | 29340 | — |
| Velocity Clinical Research, Spartanburg | Spartanburg | South Carolina | 29303 | — |
| AMR-Knoxville | Knoxville | Tennessee | 37909 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| Cedar Health Research, LLC | Dallas | Texas | 75251 | — |
| Benchmark Research | Fort Worth | Texas | 76135 | — |
| DM Clinical Research - Martin Diagnostic Clinic | Houston | Texas | 77065 | — |
| ACRC trials Parent HQ | Plano | Texas | 75024 | — |
| DM Clinical Research | Tomball | Texas | 77375 | — |
| BBCR Holdings LLC dba JBR Clinical Research - Midvale Campus | Salt Lake City | Utah | 84107 | — |
| Velocity Clinical Research, Salt Lake City | West Jordan | Utah | 84088 | — |
| Velocity Clinical Research, Suffolk | Suffolk | Virginia | 23435 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06015282, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2025 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06015282 live on ClinicalTrials.gov.